27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
In line with the wider US M&A markets, PE deals held firm through 2019 with 1,329 buyouts, worth US$...
Read More >
Goldman Sachs is reportedly in negotiations with federal prosecutors to resolve claims about its rol...
Read More >
There is nothing more inspiring than hearing about someone who has been there and done that. In tod...
Read More >
U.S. Citizenship and Immigration Services (USCIS) recently announced that it would begin accepting e...
Read More >
Legal System - 1. Is your jurisdiction primarily a common law, civil law, customary law or theocra...
Read More >
How does the Equal Employment Opportunity Commission evaluate discrimination complaints? What trend...
Read More >